|Harte Hanks Inc （HARTE-HANKS）
|ハート・ハンクス(Harte-Hanks Inc.)は地元・地方・国家・国際の消費者及び企業間の販売業者に、直販サービス及びショッパー広告業務を提供する世界的なダイレクトマーケティング会社。同社は国内外で事業を行う直接販売事業部門及びカリフォルニア州・フロリダ州の地元・地方市場で事業を展開するショッパー事業部門により構成される。Harte-Hanks Shoppersはショッパー出版物を所有・経営・提供する会社(発行部数と収入に基づく)。平成23年12月期決算期において、直接販売事業の収益とショッパー事業の収益はそれぞれ同社の総収益の72%と28％を占めた。 ハ―ト・ハンクスは、米国のマ―ケティング会社。ウェブサイトの開発、デザインなどの代理店・デジタルサ―ビス、デ―タベ―スマ―ケティングソリュ―ションのほか、デ―タクレンジング・名寄せツ―ルの「トリリアム」ソフトウェア、デジタル印刷や発送業務などのダイレクトメ―ルサ―ビス、さらに多言語対応のカスタマ―サ―ビスを提供する。 Harte Hanks is a leading global customer experience company whose mission is to partner with clients to provide them with CX strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract, and engage their customers. Using its unparalleled resources and award-winning talent in the areas of Customer Care, Fulfillment and Logistics, and Marketing Services, Harte Hanks has a proven track record of driving results for some of the world's premier brands including Bank of America, GlaxoSmithKline, Unilever, Pfizer, HBOMax, Volvo, Ford, FedEx, Midea, Sony and IBM among others. Headquartered in Austin, Texas, Harte Hanks has over 2,500 employees in offices across the Americas, Europe, and Asia Pacific.
|9601 McAllister Freeway Suite 610 San Antonio TX 78216 USA
|Alfred V. Tobia
|Chairman of the Board
|BRIEF: For the fiscal year ended 31 December 2018 Harte Hanks Inc revenues decreased 26% to $284.6M. Net income applicable to common stockholders excluding extraordinary items totaled $14.9M vs. loss of $45.3M. Revenues reflect United States segment decrease of 26% to $243.3M Other Countries segment decrease of 22% to $41.3M. Net Income reflects Gain on sale increase from $0K to $31M (income) Advertising Expenses decrease of 15% to $34.2M (expense).
Amicus Briefs Filed in Suit to End Policy that Prohibits Copay Assistance from Counting toward Patients’ Out-of-Pocket Spending 2023/02/10 16:50:00 Accesswire
WASHINGTON, DC / ACCESSWIRE / February 10, 2023 / Yesterday, 29 patient, provider, and consumer organizations representing a wide range of illnesses and health conditions filed an amicus brief in support of a case brought against the U.S. Department of Health and Human Services by the HIV+Hepatitis Policy Institute , the Diabetes Leadership Council , the Diabetes Patient Advocacy Coalition , and three patients. Filed in the U.S. District Court for the District of Columbia, the lawsuit challenges the federal 2021 Notice of Benefit and Payment Parameters rule, which allows health insurers to avoid counting the value of drug manufacturer copay assistance toward patients'' out-of-pocket cost obligations. Plaintiffs recently filed a motion for summary judgment, asserting that the rule violates cost-sharing requirements mandated by the Affordable Care Act and is also arbitrary and capricious. The amicus brief organized by Aimed Alliance demonstrates how copay accumulator policies acutely harm the patient community.
Medicare mulls rebates in 2025 for drug prices rising faster than inflation 2023/02/10 12:18:08 Seeking Alpha
The U.S. Department of Health and Human Services ((HHS)) announced that Medicare will start collecting rebates from drugmakers in 2025 when they raise prescription drug prices faster…
The Covid emergency in the U.S. ends May 11. HHS officials say here''s what to expect 2023/02/09 23:19:13 CNBC
HHS officials in call with reporters laid out what the the public can expect when the emergency ends.
First on CNN: HHS secretary sends letter to state governors on what''s to come when Covid-19 public health emergency ends 2023/02/09 21:08:16 CNN
Plans are moving forward at the US Department of Health and Human Services to prepare for the end of the nation''s Covid-19 public health emergency declaration in May.
State sues Biden for forcing drug stores to carry abortion pills 2023/02/08 15:17:37 WND
(Image by HeungSoon from Pixabay ) By Katelynn Richardson Daily Caller News Foundation Texas Attorney General Ken Paxton filed a lawsuit against President Joe Biden’s Department of Health and Human Services (HHS) Tuesday over the agency’s guidance mandating pharmacies provide abortion pills regardless of state law. The HHS issued the guidance in July 2022, citing federal anti-discrimination law and threatening to pull Medicaid and Medicare funds from pharmacies that do not comply. The lawsuit argues that the guidance contradicts the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, which found no constitutional right to an abortion and kicked the ability to pass regulations back to the state level. “The guidance makes clear that as recipients of federal financial assistance, including Medicare and Medicaid payments, pharmacies are prohibited under law from discriminating based on race, color, national origin, sex, age, and disability in their programs and activities,” the HHS wrote last July.
Florida sues FDA amid claims it is stalling plans to import prescription drugs from Canada 2022/09/01 19:58:55 Daily Mail Online
Florida is suing the FDA and HHS in a bid to begin importing prescription drugs from Canada to make them cheaper in the U.S. The legislature passed a law importing the imports in 2019.
HHS planning for private sector to foot bill for COVID-19 vaccine doses by January 2022/08/31 21:14:31 Washington Examiner
The federal government warned that it anticipates running out of money to purchase or distribute COVID-19 vaccine doses as early as January next year without funding from Congress and is preparing to offload the bill for vaccine doses, tests, and antivirals to insurers and people.
Patient groups sue HHS over co-pay assistance program 2022/08/31 13:24:11 InsuranceNewsNet
Groups representing HIV and diabetes patients are trying to scrap a Medicare rule they say leaves sick patients stuck with higher drug costs, by preventing them from applying billions of dollars in assistance against their insurance deductibles. The big picture: A federal suit filed by the groups on Tuesday takes up the bigger question of whether pharmaceutical companies can cover…
Biden administration injects $11M into monkeypox vaccine production 2022/08/29 20:19:54 The Hill
The Department of Health and Human Services (HHS) on Monday announced it is providing about $11 million of funding to support domestic production of the Jynneos smallpox vaccine being used to limit the spread of the ongoing monkeypox outbreak. HHS said in a statement that the funds would be used to support manufacturing at the…